Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Esperion Therapeutics, Inc. | StockGist | StockGist

Companies
ESPR
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ESPRSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Esperion Therapeutics, Inc.

Filed Nov 14, 2025

Accepted Nov 13, 2025, 7:00 PM ET

CIK 0001434868

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

9,749,724

Reporting Person

Esperion Therapeutics, Inc.

Person Type

IA

CUSIP: 29664W105

Key Facts

Shares Owned

9,749,724

Recent Filings

Esperion Therapeutics, Inc.4 days ago

Esperion Therapeutics, Inc.3 weeks ago

Esperion Therapeutics, Inc.3 weeks ago

Esperion Therapeutics, Inc.1 months ago

Esperion Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice